Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Comment
. 2022 Nov 1;107(11):2534-2535.
doi: 10.3324/haematol.2022.280658.

Mature T-cell neoplasms and stem cell transplant: the never-ending story

Affiliations
Comment

Mature T-cell neoplasms and stem cell transplant: the never-ending story

Emmanuel Bachy. Haematologica. .
No abstract available

PubMed Disclaimer

Comment on

References

    1. Horwitz S, O'Connor OA, Pro B, et al. . The ECHELON-2 trial: 5-year results of a randomized, phase III study of brentuximab vedotin with chemotherapy for CD30-positive peripheral T-cell lymphoma. Ann Oncol. 2022;33(3):288-298. - PMC - PubMed
    1. Corradini P, Tarella C, Zallio F, et al. . Long-term follow-up of patients with peripheral T-cell lymphomas treated up-front with high-dose chemotherapy followed by autologous stem cell transplantation. Leukemia. 2006;20(9):1533-1538. - PubMed
    1. d'Amore F, Relander T, Lauritzsen GF, et al. . Up-front autologous stem-cell transplantation in peripheral T-cell lymphoma: NLG-T-01. J Clin Oncol. 2012;30(25):3093-3099. - PubMed
    1. Mercadal S, Briones J, Xicoy B, et al. . Intensive chemotherapy (high-dose CHOP/ESHAP regimen) followed by autologous stem-cell transplantation in previously untreated patients with peripheral T-cell lymphoma. Ann Oncol. 2008;19(5):958-963. - PubMed
    1. Reimer P, Rudiger T, Geissinger E, et al. . Autologous stem-cell transplantation as first-line therapy in peripheral T-cell lymphomas: results of a prospective multicenter study. J Clin Oncol. 2009;27(1):106-113. - PubMed